Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Bronx, NY
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Buffalo, NY
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Buffalo, NY
Click here to add this to my saved trials
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
New York, NY
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Staten Island, NY
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Staten Island, NY
Click here to add this to my saved trials
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Avon Lake, OH
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Avon Lake, OH
Click here to add this to my saved trials
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Mason, OH
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Mason, OH
Click here to add this to my saved trials
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Memphis, TN
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
San Antonio, TX
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Bothell, WA
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Bothell, WA
Click here to add this to my saved trials
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Spokane, WA
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Waukesha, WI
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Waukesha, WI
Click here to add this to my saved trials
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Birmingham, AL
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated:  2/16/2016
Study Site
mi
from
Bourgas,
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects
Status: Enrolling
Updated: 2/16/2016
Study Site
mi
from
Bourgas,
Click here to add this to my saved trials
Topiramate to Reduce Heavy Drinking in HIV-Positive Heavy Drinkers
Topiramate to Reduce Heavy Drinking in HIV-Positive Heavy Drinkers
Status: Enrolling
Updated:  2/16/2016
University of Pennsylvania, Treatment Research Center
mi
from
Philadelphia, PA
Topiramate to Reduce Heavy Drinking in HIV-Positive Heavy Drinkers
Topiramate to Reduce Heavy Drinking in HIV-Positive Heavy Drinkers
Status: Enrolling
Updated: 2/16/2016
University of Pennsylvania, Treatment Research Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Intervention Targeting Substance Using Older Adults With HIV
Intervention Targeting Substance Using Older Adults With HIV
Status: Enrolling
Updated:  2/17/2016
Center for HIV/AIDS Educational Studies and Training of Hunter College, CUNY
mi
from
New York, NY
Intervention Targeting Substance Using Older Adults With HIV
Intervention Targeting Substance Using Older Adults With HIV
Status: Enrolling
Updated: 2/17/2016
Center for HIV/AIDS Educational Studies and Training of Hunter College, CUNY
mi
from
New York, NY
Click here to add this to my saved trials
Develop and Validate a Self-Administered Instrument That Will Screen for Eating Disorder Symptoms in Persons Aged 12 and Older With Type 1 Diabetes.
Development of an Instrument to Screen for Eating Disorder Symptoms in Persons With Type 1 Diabetes
Status: Enrolling
Updated:  2/17/2016
International Diabetes Center
mi
from
Minneapolis, MN
Develop and Validate a Self-Administered Instrument That Will Screen for Eating Disorder Symptoms in Persons Aged 12 and Older With Type 1 Diabetes.
Development of an Instrument to Screen for Eating Disorder Symptoms in Persons With Type 1 Diabetes
Status: Enrolling
Updated: 2/17/2016
International Diabetes Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Develop and Validate a Self-Administered Instrument That Will Screen for Eating Disorder Symptoms in Persons Aged 12 and Older With Type 1 Diabetes.
Development of an Instrument to Screen for Eating Disorder Symptoms in Persons With Type 1 Diabetes
Status: Enrolling
Updated:  2/17/2016
International Diabetes Center
mi
from
Minneapolis, MN
Develop and Validate a Self-Administered Instrument That Will Screen for Eating Disorder Symptoms in Persons Aged 12 and Older With Type 1 Diabetes.
Development of an Instrument to Screen for Eating Disorder Symptoms in Persons With Type 1 Diabetes
Status: Enrolling
Updated: 2/17/2016
International Diabetes Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Does Hydroxyzine Decrease Anxiety in Underweight Patients Diagnosed With an Eating Disorder
Hydroxyzine Effects on Meal-Related Anxiety in Underweight Adolescents and Young Adults Diagnosed With an Eating Disorder - A Pilot Study
Status: Enrolling
Updated:  2/17/2016
Melrose Institute
mi
from
Minneapolis, MN
Does Hydroxyzine Decrease Anxiety in Underweight Patients Diagnosed With an Eating Disorder
Hydroxyzine Effects on Meal-Related Anxiety in Underweight Adolescents and Young Adults Diagnosed With an Eating Disorder - A Pilot Study
Status: Enrolling
Updated: 2/17/2016
Melrose Institute
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Increasing Treatment Seeking Among Suicidal Veterans Calling the Crisis Line
Increasing Treatment Seeking Among Suicidal Veterans Calling the Crisis Line
Status: Enrolling
Updated:  2/17/2016
Canandaigua VA Medical Center, Canandaigua, NY
mi
from
Canandaigua, NY
Increasing Treatment Seeking Among Suicidal Veterans Calling the Crisis Line
Increasing Treatment Seeking Among Suicidal Veterans Calling the Crisis Line
Status: Enrolling
Updated: 2/17/2016
Canandaigua VA Medical Center, Canandaigua, NY
mi
from
Canandaigua, NY
Click here to add this to my saved trials
Increasing Treatment Seeking Among Suicidal Veterans Calling the Crisis Line
Increasing Treatment Seeking Among Suicidal Veterans Calling the Crisis Line
Status: Enrolling
Updated:  2/17/2016
White River Junction VA Medical Center, White River Junction, VT
mi
from
White River Junction, SC
Increasing Treatment Seeking Among Suicidal Veterans Calling the Crisis Line
Increasing Treatment Seeking Among Suicidal Veterans Calling the Crisis Line
Status: Enrolling
Updated: 2/17/2016
White River Junction VA Medical Center, White River Junction, VT
mi
from
White River Junction, SC
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated:  2/17/2016
UCLA
mi
from
Los Angeles, CA
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated:  2/17/2016
Synergy Clinical Research
mi
from
National City, CA
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Synergy Clinical Research
mi
from
National City, CA
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated:  2/17/2016
Newport Beach Clinical Research Associates, Inc.
mi
from
Newport Beach, CA
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Newport Beach Clinical Research Associates, Inc.
mi
from
Newport Beach, CA
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated:  2/17/2016
Orange County Neuro Phychiatry Research Centre
mi
from
Orange, CA
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Orange County Neuro Phychiatry Research Centre
mi
from
Orange, CA
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated:  2/17/2016
Florida Clinical Research Center, LLC
mi
from
Bradenton, FL
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Florida Clinical Research Center, LLC
mi
from
Bradenton, FL
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated:  2/17/2016
Sarkis Clinical Research
mi
from
Gainesville, FL
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Sarkis Clinical Research
mi
from
Gainesville, FL
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated:  2/17/2016
Sarkis Clinical Trials
mi
from
Gainesville, FL
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Sarkis Clinical Trials
mi
from
Gainesville, FL
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated:  2/17/2016
CNS Healthcare Jacksonville
mi
from
Jacksonville, FL
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
CNS Healthcare Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated:  2/17/2016
Florida Clinical Research Center
mi
from
Maitlin, FL
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Florida Clinical Research Center
mi
from
Maitlin, FL
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated:  2/17/2016
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated:  2/17/2016
Stedman Clinical Trials
mi
from
Tampa, FL
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Stedman Clinical Trials
mi
from
Tampa, FL
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated:  2/17/2016
Advanced Clinical Research
mi
from
Boise, ID
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Advanced Clinical Research
mi
from
Boise, ID
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated:  2/17/2016
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated:  2/17/2016
Princeton Medical Institute
mi
from
Princeton, NJ
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Princeton Medical Institute
mi
from
Princeton, NJ
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated:  2/17/2016
The Medical Research Network, LLC
mi
from
New York, NY
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Medical Research Network, LLC
mi
from
New York, NY
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated:  2/17/2016
Wake Research Associates, LLC
mi
from
Raleigh, NC
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated:  2/17/2016
University of Cincinnati
mi
from
Cincinnati, OH
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated:  2/17/2016
IPS Research Company
mi
from
Oklahoma City, OK
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
IPS Research Company
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated:  2/17/2016
Oregon Center for Clinical Investigation
mi
from
Portland, OR
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Oregon Center for Clinical Investigation
mi
from
Portland, OR
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated:  2/17/2016
Oregon Center for Clinical Investigation
mi
from
Salem, OR
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Oregon Center for Clinical Investigation
mi
from
Salem, OR
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated:  2/17/2016
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated:  2/17/2016
FutureSearch Clinical Trials LP
mi
from
Austin, TX
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
FutureSearch Clinical Trials LP
mi
from
Austin, TX
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated:  2/17/2016
FutureSearch Trials of Dallas, LP
mi
from
Dallas, TX
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
FutureSearch Trials of Dallas, LP
mi
from
Dallas, TX
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated:  2/17/2016
Bayou City Research, Ltd.
mi
from
Houston, TX
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Bayou City Research, Ltd.
mi
from
Houston, TX
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated:  2/17/2016
Red Oak Psychiatry Associates, PA
mi
from
Houston, TX
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Red Oak Psychiatry Associates, PA
mi
from
Houston, TX
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated:  2/17/2016
Houston Clinical Trials, LLC
mi
from
Houston, TX
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Houston Clinical Trials, LLC
mi
from
Houston, TX
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated:  2/17/2016
Westex Clinical Investigations
mi
from
Lubbock, TX
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Westex Clinical Investigations
mi
from
Lubbock, TX
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated:  2/17/2016
Ericksen Research
mi
from
Clinton, UT
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Ericksen Research
mi
from
Clinton, UT
Click here to add this to my saved trials